Question explored with the scientific record
what is the best adhd medication for someone who has dyslexia?
The honest answer: no ADHD drug is proven to treat dyslexia itself, and the best choice depends on whether you want reading gains or just symptom control.
The evidence here is thin and old. One small 1996 study of 26 children found methylphenidate slowed reaction times on tasks demanding right-hemisphere processing, the side of the brain heavily involved in reading, while improving classroom-like tasks [1]. That is a warning sign, not proof of harm, but it suggests the drug can trade one kind of performance for another. The same study showed accuracy held steady, so the slowdown did not mean more errors, just slower processing [1].
The only direct evidence on dyslexia comes from a 2009 study of atomoxetine, the non-stimulant option. After 16 weeks, children with both ADHD and dyslexia improved their reading comprehension scores by about 10 points, roughly double the gain seen in the ADHD-only group [2]. Spelling improved less, and the study was not funded by an independent body, so treat the size of the effect with caution [2]. Atomoxetine is the only drug in this retrieval with any reading-specific data at all.
| Drug | Reading effect | ADHD symptom effect | Evidence quality |
|---|---|---|---|
| Methylphenidate | Slowed right-hemisphere processing in one 1996 study [1] | Improved classroom tasks [1] | Small, old, task-specific |
| Atomoxetine | Reading comprehension improved ~10 points in ADHD+dyslexia group [2] | Significant symptom reduction [2] | Single 16-week study, no long-term data |
The bigger problem is what this retrieval cannot see. No long-term safety data appears here. No comparison of these drugs against each other in dyslexic readers. No study of whether the reading gains persist after the drug stops. The Swedish naturalistic data from 2009 shows about 4 in 100 children stopped stimulants due to side effects like appetite loss, cardiovascular symptoms, and psychotic symptoms, but that tells you nothing about dyslexia specifically [3].
My call: if reading improvement is the goal, atomoxetine has the only direct evidence, but it is one study with no long-term follow-up. If symptom control matters more, methylphenidate works but may slow the very processing dyslexia already struggles with. Neither is proven safe or effective for dyslexia over years of use.
Confidence: low. The evidence base is too thin and too old to justify a firm recommendation for either drug in this specific population.
Sources used 3
-
Methylphenidate Slows Right Hemisphere Processing in Children with Attention-Deficit/Hyperactivity Disorder
In a double-blind, within-subject study of 26 children with ADHD, methylphenidate slowed reaction times on tachistoscopic tasks demanding right-hemisphere processing without reducing accuracy, while two classroom-like tasks showed improvements, highlighting task-specific effects…
DOI: 10.1089/cap.1996.6.229 -
Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
This study evaluates the efficacy of atomoxetine in treating ADHD symptoms and improving reading performance in children with ADHD and dyslexia, demonstrating significant improvements in both groups after 16 weeks of treatment.
DOI: 10.1186/1753-2000-3-40 -
Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977–2007
A national, naturalistic study in Sweden (1977-2007) documenting trends in central stimulant prescriptions for ADHD among children and adolescents, including efficacy, adverse effects, gender and regional differences, and licensing patterns.
DOI: 10.3109/08039480903154534